Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-Pyridoxyl–1-Amino–Cyclopropanecarboxylic Acid–5-Monophosphate is a synthetic small molecule containing a pyridoxamine (vitamin B6 derivative) moiety with a phosphate group at the 5' position, linked to an aminocyclopropanecarboxylic acid. It is primarily of interest as an experimental compound in biochemical and medicinal chemistry research, particularly for its structural features—such as the cyclopropane ring and phosphono group—which may influence interactions with enzymes or receptors. There are no approved therapeutic indications or known clinical uses for this compound, and it has not advanced beyond experimental status in drug development[1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N-Pyridoxyl-1-Amino-Cyclopropanecarboxylic Acid-5-Monophosphate.